NEW YORK (GenomeWeb News) – Nanogen said on Friday after the close of the market that it has received a letter from Nasdaq stating that the firm is subject to delisting proceedings because it has not paid certain outstanding fees as required for continued listing on the exchange.

Nanogen said that it currently plans not to appeal the delisting notice, which means trading in its common stock would be suspended at the opening of business on March 23.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.